|
RBMX expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.624400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.537600E-01 |
| Normal-vs-Stage2 |
5.266800E-01 |
| Normal-vs-Stage3 |
2.679400E-01 |
| Normal-vs-Stage4 |
1.216570E-01 |
| Stage1-vs-Stage2 |
5.420200E-01 |
| Stage1-vs-Stage3 |
3.254800E-01 |
| Stage1-vs-Stage4 |
3.774100E-02 |
| Stage2-vs-Stage3 |
8.707600E-01 |
| Stage2-vs-Stage4 |
2.883600E-01 |
| Stage3-vs-Stage4 |
2.370800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.323800E-01 |
| Normal-vs-AfricanAmerican |
1.746370E-01 |
| Normal-vs-Asian |
8.879000E-01 |
| Caucasian-vs-AfricanAmerican |
4.201200E-01 |
| Caucasian-vs-Asian |
6.841800E-01 |
| AfricanAmerican-vs-Asian |
5.400800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.875600E-01 |
| Normal-vs-Female |
2.240400E-02 |
| Male-vs-Female |
1.905800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.961200E-01 |
| Normal-vs-Extreme_Weight |
9.828400E-01 |
| Normal-vs-Obese |
7.220300E-02 |
| Normal-vs-Extreme_Obese |
3.705200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.708800E-01 |
| Normal_Weight-vs-Obese |
4.983600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.997000E-01 |
| Extreme_Weight-vs-Obese |
6.239900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.907200E-01 |
| Obese-vs-Extreme_Obese |
1.260970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.669710E-02 |
| Normal-vs-Age(41-60Yrs) |
2.494100E-02 |
| Normal-vs-Age(61-80Yrs) |
8.286000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.413200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.527200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.798100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.657800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.035100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.215800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.873200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.624620E-01 |
| Normal-VS-Type2 PRCC |
8.465800E-01 |
| Normal-VS-KIRP CIMP |
3.313600E-01 |
| Normal-VS-Unclassified PRCC |
5.058400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.140820E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.449400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.693200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.547400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.347200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.178800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.341400E-01 |
| Normal-vs-N1 |
1.193860E-02 |
| Normal-vs-N2 |
1.715230E-01 |
| N0-vs-N1 |
5.402400E-03 |
| N0-vs-N2 |
1.545360E-01 |
| N1-vs-N2 |
6.431000E-01 |
|
|
